Barclays PLC Sanara Med Tech Inc. Transaction History
Barclays PLC
- $854 Billion
- Q3 2025
A detailed history of Barclays PLC transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Barclays PLC holds 7,750 shares of SMTI stock, worth $166,625. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,750
Previous 8,853
12.46%
Holding current value
$166,625
Previous $252,000
4.37%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SMTI
# of Institutions
56Shares Held
1.11MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$4.24 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA182KShares$3.91 Million0.0% of portfolio
-
Stonebridge Wealth Management, LLC Oak Brook, IL115KShares$2.46 Million3.12% of portfolio
-
Geode Capital Management, LLC Boston, MA78.5KShares$1.69 Million0.0% of portfolio
-
Marshall Wace, LLP London, X066.1KShares$1.42 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $179M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...